Covered recipient · General Payments record
PATRICIA G JONES NICE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$2,927.37
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.04 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $251.15 | 14 |
| Supernus Pharmaceuticals, Inc. | $112.59 | 3 |
| Janssen Pharmaceuticals, Inc | $23.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.97 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010230 | CMS |
| ABBVIE INC. | $10.43 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010232 | CMS |
| ABBVIE INC. | $9.10 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010234 | CMS |
| ABBVIE INC. | $46.75 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010236 | CMS |
| ABBVIE INC. | $27.40 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010238 | CMS |
| ABBVIE INC. | $15.44 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010240 | CMS |
| ABBVIE INC. | $19.05 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010242 | CMS |
| ABBVIE INC. | $25.11 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010244 | CMS |
| ABBVIE INC. | $13.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010246 | CMS |
| ABBVIE INC. | $18.92 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010248 | CMS |
| ABBVIE INC. | $18.29 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010250 | CMS |
| ABBVIE INC. | $7.97 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010252 | CMS |
| ABBVIE INC. | $19.52 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010254 | CMS |
| ABBVIE INC. | $8.48 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010256 | CMS |
| Janssen Pharmaceuticals, Inc | $23.30 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077994536 | CMS |
| Supernus Pharmaceuticals, Inc. | $76.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147881882 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.26 | 07/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147888379 | CMS |
| Supernus Pharmaceuticals, Inc. | $23.33 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147881880 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.